The global clinical trial supplies market was valued at USD 3.60 Billion in 2025, driven by the rising number of clinical trials and technological advancements across the globe. The market is expected to grow at a CAGR of 9.10% during the forecast period of 2026-2035, with the values likely to reach USD 8.60 Billion by 2035.
Base Year
Historical Period
Forecast Period
In November 2023, AstraZeneca launched a new venture Evinova targeted to optimise clinical trial design and delivery. Such initiatives led by major healthcare companies is expected to impact the market value positively in the forecast period.
In June 2023, Medable with the MRCT Center of Brigham and Women’s Hospital and Harvard launched a toolkit developed for Institutional Review Boards (IRBs) and Ethics Committees (ECs), offering a consistent framework, tools, and best practices to enhance the ethical review and approval process for DCTs.
In May 2023, the global biopharmaceutical services provider Allucent strategically partnered with an innovative DCT and eCOA technology provider THREAD, for the collaborative launch of Allucent Patient Direct Trials.
Compound Annual Growth Rate
9.1%
Value in USD Billion
2026-2035
*this image is indicative*
Clinical trial supplies include tools and equipment used in clinical trials to determine the safety and efficacy of the subject. It can comprise of investigational products, such as drugs, medical devices, or biological substances. To meet quality standards and comply with regulatory guidelines, these supplies need to be managed and maintained appropriately. The increasing incidence of clinical trials to provide desired and effective treatment outcomes to consumers is driving the market growth. Pharmaceutical and biotech companies are increasingly taking part in the drug development process are conducting more clinical trials, propelling market growth.
Expansion of Decentralised Clinical Trial Solutions for Emerging Biotech Firms
In May 2023, the global biopharmaceutical services provider Allucent partnered with THREAD to launch Allucent Patient Direct Trials, which offers DCT and eCOA technology services. With this strategic partnership, the market witnessed a significant expansion in decentralised clinical trials for companies that are small and emerging. The partnership was intended to bring regulatory expertise technological advancements and development to such companies and facilitate the design and management of customised DCTs. The market is likely to witness substantial companies as Allucent and THREAD assist more small companies to enter the DCT space. The demand for customised digital and logistical support services is expected to escalate as more firms engage in such innovative trial formats. The market is poised to witness an upward trajectory by rising enhancement, speed, and flexibility of clinical research.
Standardising Decentralised Clinical Trials to Enhance Efficiency
In June 2023, Medable Inc., a prominent technology provider for patient-centric clinical trials, with the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard (MRCT Center), launched an innovative toolkit for Institutional Review Boards (IRBs)/Ethics Committees (ECs) to standardise the ethical review of decentralised clinical trials (DCTs). This innovative toolkit delivered a unified framework, equipped with tools and best practices, aimed at assisting the ethical review and approval procedures, for the ethical conduct of decentralised clinical trials DCTs.
As DCTs enable rapid execution of clinical studies, the standardisation facilitated by this toolkit could prevent potential slowdowns due to disjointed and inconsistent ethics reviews, which were identified as critical barriers by the National Institutes of Health and other industry groups. This move is expected to enhance operational efficiency across the global clinical trial supply chain, encouraging wider adoption of DCT methodologies and supporting a shift towards more innovative and responsive clinical research frameworks. Consequently, the clinical trial supplies market is poised to experience significant growth, driven by increased demand for specialised services and supplies aligning with the streamlined DCT models.
Surge in New Launches to Meet Rising Global Clinical Trial Supplies Market Demand
In November 2023, AstraZeneca launched a new venture Evinova intended to provide digital health solutions. AstraZeneca’s strategic collaborations with Parexel and Fortrea enabled Evinova to provide scaled digital technology solutions that have been used by AstraZeneca in 40 countries. This new venture aimed at revolutionising the global clinical trials landscape by offering digital health solutions and optimise clinical trial design and delivery. Such advanced technological solutions are likely to escalate market demand for similar solutions, fostering the adoption of home-based trial models. This could result in significant market growth, recording a shift towards more integrated, patient-centric clinical research procedures.
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
Clinical Trial Supplies Market Report and Forecast 2026-2035 offers a detailed analysis of the market based on the following segments:
Market Breakup by Phase
Market Breakup by Type
Market Breakup by Therapeutic Use
Market Breakup by End Use
Market Breakup by Region
Oncology Expected to Dominate the Market Share Based on Therapeutic Use
The therapeutic use segmentation consists of oncology, CNS, cardiovascular, infectious diseases, metabolic disorders, and others. With the increasing prevalence of cancer worldwide, the incidence of oncology clinical trials is on the rise. It is a leading segment as pharmaceutical and biotechnology companies are continuously finding opportunities to discover innovative and effective therapeutics for the treatment of cancer.
Pharmaceuticals and Biotechnology Companies, Common End Users of Clinical Trial Supplies
By end users’ segmentation, the market is divided into pharmaceutical companies, biotechnology companies, contract research organisations, and others. Out of these, pharmaceutical, and biotechnology companies are the common end users of clinical trial supplies, owing to its crucial role in drug development process. They perform extensive clinical trials to analyse the efficacy and safety of new drugs and therapies. Due to this, a decent supply of materials, including drugs, placebos, and lab equipment is required by these companies contributing to its market growth.
Based on the regional analysis, the market report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, with each region contributing to the overall dynamics of the market. North America is leading the regional market with increasing advancements in technologies for making clinical trials more convenient and cost-effective. The presence of a robust healthcare infrastructure and the rising number of clinical trials in the region are propelling the demand for clinical trial supplies in the market. Asia Pacific is following the region and becoming a preferred region for conducting clinical trials by market players. The market growth can be attributed to the presence of a diverse population in the region.
The key features of the market report include funding and investment analysis, and strategic initiatives such as recent partnerships, and collaborations analysis by the leading players. The major companies in the market are as follows:
Based out of United States and established in 1956, Thermo Fisher Scientific is a key player of the clinical trials market. It offers a comprehensive range of solutions including packaging, labelling, distribution, and logistics. The platforms offered by the company, further support efficient supply chain of the resources.
Eurofins Scientific is involved in multiple domains and services such as pharmaceutical services, food testing, environmental testing, and clinical diagnostics. It boasts a prominent product portfolio for bioanalytical, microbiology and chemistry testing for drug development and manufacturing, utilising clinical trial supplies effectively.
Parexel International Corporation was established in 1982 and is headquartered in Massachusetts, USA. The company is one of the leading contract research organisations offering regulatory consulting services to pharmaceutical, medical devices as well as biotechnology market.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other players in the market include Almac Group, Biocair, Catalent, Inc., KLIFO, Movianto, PCI Pharma Services, Sharp Services, LLC, Rubicon Research Pvt. Ltd., Recipharm AB., Piramal Pharma Solutions, NUVISAN GmbH and Myonex
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Upto 15% Off
USD
$5499 $4949
$3299 $2969
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Phase |
|
| Breakup by Type |
|
| Breakup by Therapeutic Use |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share